Nuvama Crossover Opportunites Fund-Series III

Investor· IN
Sign in for alerts
  • REDUCEDT+30

    Sudeep Pharma Limited · NSE

    26,68,118 sh

    Filed 29 Jul 2026SEBI SASTview source
  • ACQUIREDT+30

    Sudeep Pharma Limited · NSE

    +94,51,295 sh

    Filed 29 Jul 2026SEBI SASTview source